UK Approves Johnson & Johnson’s Oral Psoriasis Pill
Britain’s medicines regulator approved Johnson & Johnson’s daily pill for adults and teenagers with moderate-to-severe plaque psoriasis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.